# SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial

Study · id `cardio:ct-nct05831202` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05831202](<https://clinicaltrials.gov/study/NCT05831202>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05831202

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 279 participants.

## Technical summary

Registry record NCT05831202. Allocation not applicable; no masking; primary purpose treatment. Start 2024-08-06 (actual); primary completion 2026-09-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 279 participants (planned count; ClinicalTrials.gov record NCT05831202, source copy `cardio:ctgov-nct05831202-2026-01-16`, retrieved 2026-11-18)
- Started: 2024-08-06 (actual) (ClinicalTrials.gov record NCT05831202, source copy `cardio:ctgov-nct05831202-2026-01-16`, retrieved 2026-11-18)
- Primary completion: 2026-09-10 (anticipated) (ClinicalTrials.gov record NCT05831202, source copy `cardio:ctgov-nct05831202-2026-01-16`, retrieved 2026-11-18)
- Completion: 2030-09-10 (anticipated) (ClinicalTrials.gov record NCT05831202, source copy `cardio:ctgov-nct05831202-2026-01-16`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05831202, source copy `cardio:ctgov-nct05831202-2026-01-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05831202-2026-01-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial
- Acronym: SEAL™IT
- Condition: Intracranial Aneurysm
- Intervention (Device): The SEAL™ Saccular Endovascular Aneurysm Lattice System
- Lead sponsor: Galaxy Therapeutics INC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)

## Provenance

Content hash: 91ed01578b5d387b4b9f0d41589aa6b6be2f681a7192a2b832bcec750ef8e4b5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
